Vimpat (UCB, Inc.)
Welcome to the PulseAid listing for the Vimpat drug offered from UCB, Inc.. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | UCB, Inc. |
NON-PROPRIETARY NAME: | lacosamide |
SUBSTANCE NAME: | LACOSAMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2010-04-20 |
END MARKETING DATE: | 0000-00-00 |
Vimpat HUMAN PRESCRIPTION DRUG Details:
Item Description | Vimpat from UCB, Inc. |
LABELER NAME: | UCB, Inc. |
DEA SCHEDULE: | CV
|
ACTIVE STRENGTH: | 10(mg/mL) |
START MARKETING DATE: | 2010-04-20 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0131-5410_acf39515-db07-4e03-bef4-2eca474a874d |
PRODUCT NDC: | 0131-5410 |
APPLICATION NUMBER: | NDA022255 |
Other LACOSAMIDE Pharmaceutical Manufacturers / Labelers: